On June 9, 2025, Microbot Medical Inc. announced the hiring of Michael Lytle as head of Sales Operations & Analytics, preparing for the U.S. launch of the LIBERTY System expected in Q3 2025; an FDA decision on the system is also anticipated in that timeframe.